IR@PKUHSC  > 北京大学药学院  > 药剂学系
学科主题药学
The antiangiogenic efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in rats
Zhao, Bo-Jun1; Ke, Xi-Yu1; Huang, Yue1; Chen, Xiao-Mei1; Zhao, Xin1; Zhao, Bing-Xiang1; Lu, Wan-liang1,2; Lou, Jin-Ning3; Zhang, Xuan1; Zhang, Qiang1,2
关键词Aminopeptidase N (APN) Asn-Gly-Arg (NGR) paclitaxel (PTX) DSPE-PEG micelles brain glioma-bearing rats antitumor efficacy
刊名JOURNAL OF DRUG TARGETING
2011-06-01
DOI10.3109/1061186X.2010.504267
19期:5页:382-390
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Pharmacology & Pharmacy
研究领域[WOS]Pharmacology & Pharmacy
关键词[WOS]CATIONIC LIPOSOMES ; AMINOPEPTIDASE-N ; FIGHTING CANCER ; BRAIN-TUMORS ; MOUSE MODEL ; IN-VITRO ; CHEMOTHERAPY ; BINDING ; CELLS ; ANGIOGENESIS
英文摘要

Aminopeptidase N (APN), recognized by Asn-Gly-Arg (NGR) peptides, is expressed in the pericytes associated with the BBB, and the main objective of this study is to confirm the hypothesis that NGR-modified DSPE-PEG micelles containing paclitaxel (NGR-M-PTX) can bind to and kill brain tumor angiogenic blood vessels and penetrate into the brain tumor interstitial space, resulting in direct cell death. NGR-M-PTX is prepared by a thin-film hydration method. The in vitro targeting characteristics of NGR-modified micelles on BMEC (murine brain microvascular endothelial cells) were investigated. The effect of NGR-M-PTX on BMEC proliferation and the cytotoxicity of NGR-M-PTX in C6 glioma cells were also tested. The antitumor activity NGR-M-PTX was evaluated in C6 glioma tumor-bearing rats in vivo. The particle size of NGR-M-PTX was approximately 54.2 nm. The drug encapsulation efficiency of NGR-M-PTX was 82.11 +/- 2.82%. The cellular coumarin-6 level of NGR-M-coumarin-6 in the BMEC was about 2.2-fold higher than that of M-coumarin-6. BMEC proliferation was significantly inhibited by NGR-M-PTX. NGR-M-PTX had a much lower IC(50) value than M-PTX and free drug. The growth of C6 glioma tumor was markedly inhibited by NGR-M-PTX compared with Taxol. In conclusion, our results show that antiangiogenic therapy using NGR-M-PTX exhibits potent in vivo antitumor activity in a C6 glioma-bearing animal model.

语种英语
WOS记录号WOS:000289995200008
项目编号30873170 ; 2007CB935800 ; 2009CB930300
资助机构National Natural Science Foundation of China ; National Basic Research Program of China (973 Program)
引用统计
被引频次:38[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/67418
专题北京大学药学院_药剂学系
作者单位1.Peking Univ, Sch Pharmaceut Sci, Dept Pharmaceut, Beijing 100191, Peoples R China
2.Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China
3.China Japan Friendship Hosp, Minist Hlth, Inst Clin Med Sci, Beijing 100029, Peoples R China
推荐引用方式
GB/T 7714
Zhao, Bo-Jun,Ke, Xi-Yu,Huang, Yue,et al. The antiangiogenic efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in rats[J]. JOURNAL OF DRUG TARGETING,2011,19(5):382-390.
APA Zhao, Bo-Jun.,Ke, Xi-Yu.,Huang, Yue.,Chen, Xiao-Mei.,Zhao, Xin.,...&Zhang, Qiang.(2011).The antiangiogenic efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in rats.JOURNAL OF DRUG TARGETING,19(5),382-390.
MLA Zhao, Bo-Jun,et al."The antiangiogenic efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in rats".JOURNAL OF DRUG TARGETING 19.5(2011):382-390.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhao, Bo-Jun]的文章
[Ke, Xi-Yu]的文章
[Huang, Yue]的文章
百度学术
百度学术中相似的文章
[Zhao, Bo-Jun]的文章
[Ke, Xi-Yu]的文章
[Huang, Yue]的文章
必应学术
必应学术中相似的文章
[Zhao, Bo-Jun]的文章
[Ke, Xi-Yu]的文章
[Huang, Yue]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。